Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
Patients with cardiac sarcoidosis are at increased risk of ventricular tachycardia/fibrillation.We tested the hypothesis that the wearable cardioverter defibrillator can be used to mitigate the risk of sudden cardiac death among cardiac sarcoidosis patients.A retrospective review of the commercial d...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5864098?pdf=render |